In addition, higher CXCL13 sera levels were detected in patients who survived COVID-19 compared to those in patients that did not survive, suggesting that CXL13 sera levels can be used as a novel predictor of the lethality of SARS-CoV-2 infection. Here, CXCL13 is linked to COVID-19.